Scientific Session
Interstitial Lung Disease
Daniel Culver
Cleveland Clnic
Cleveland, Ohio, United States
Disclosure(s): aTyr: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Boehringer Ingelheim Vetmedica GmbH: Consultant (Ongoing), Grant/Research Support (Ongoing); Fibrogen: Advisor or Review Panel Member (Terminated, June 30, 2024); Foresee: Advisor or Review Panel Member (Ongoing); Kinevant: Advisor or Review Panel Member (Terminated, January 1, 2025), Grant/Research Support (Terminated, January 1, 2025); Merck/MSD: Consultant (Ongoing); Molecure: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Pliant: Advisor or Review Panel Member (Ongoing)